k.wojcik
Submits third-party assay reports on material purchased directly. Based in Faro.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.03%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041436 | BPC-157 | QYB | QYB-2601-D4733 | Janoshik | 2026-Q2 | 99.85 | 3.95 | 89.9 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-041983 | Semaglutide | TFC | TFC-2602-H5189 | Janoshik | 2026-Q1 | 99.16 | 2.01 | 99.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042421 | Semaglutide | SWB | SWB-2602-W5529 | Medutest | 2026-Q1 | 99.33 | 5.63 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042444 | MGF | SWB | SWB-2601-E6319 | Janoshik | 2026-Q1 | 98.97 | 4.41 | 97.0 | Supplier-supplied | 0 | PASS |
| AX-2025-020240 | MOTS-c | GGPeps | GGPE-2508-J1903 | Janoshik | 2025-Q4 | 99.40 | 4.44 | 104.9 | Supplier-supplied | 0 | PASS |
| AX-2025-020597 | Tirzepatide | SSA | SSA-2502-D7115 | PeptideMeter | 2025-Q3 | 98.15 | 7.38 | 102.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020976 | MK-677 (Ibutamoren mesylate) | CPC | CPC-2503-G3418 | Janoshik | 2025-Q2 | 98.16 | 5.57 | 91.4 | Supplier-supplied | 1 | FAIL |
| AX-2025-020218 | Tirzepatide | GGPeps | GGPE-2412-M1040 | Janoshik | 2025-Q2 | 97.91 | 3.97 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005308 | Semaglutide | GL Biochem | GLBI-2401-F8702 | Janoshik | 2024-Q1 | 99.03 | 3.89 | — | Supplier-supplied | 1 | MARGINAL |